|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0009247,
umls-concept:C0013203,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0026882,
umls-concept:C0085405,
umls-concept:C0205466,
umls-concept:C0241315,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-5-28
|
|
pubmed:abstractText |
To assess the prognostic significance of drug-associated mutations in the protease and reverse transcriptase (RT) genes on virological response to salvage therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
4
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
F17-21
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10202819-Anti-HIV Agents,
pubmed-meshheading:10202819-Dideoxynucleosides,
pubmed-meshheading:10202819-Drug Resistance, Microbial,
pubmed-meshheading:10202819-Female,
pubmed-meshheading:10202819-Genotype,
pubmed-meshheading:10202819-HIV Infections,
pubmed-meshheading:10202819-HIV Protease,
pubmed-meshheading:10202819-HIV Protease Inhibitors,
pubmed-meshheading:10202819-HIV Reverse Transcriptase,
pubmed-meshheading:10202819-HIV-1,
pubmed-meshheading:10202819-Humans,
pubmed-meshheading:10202819-Male,
pubmed-meshheading:10202819-Mutation,
pubmed-meshheading:10202819-Predictive Value of Tests,
pubmed-meshheading:10202819-Reverse Transcriptase Inhibitors,
pubmed-meshheading:10202819-Salvage Therapy
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.
|
|
pubmed:affiliation |
AIDS Centre, Geneva University Hospital, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
